Abdus Sobur receives a 2025 Global Recognition Award for developing artificial intelligence models that support earlier ...

Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

We combine affordable thermal cameras with advanced AI to analyse temperature maps of the human body without radiation, ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

The discovery began, as many breakthroughs do, with an observation that didn’t quite make sense. In 1948, two French researchers, Paul Mandel and Pierre Métais, published a little-noticed paper in a ...

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...